Blood cancers, Myelodysplastic syndrome (MDS)
Open
Other
This study is building a record of information about a group of disorders called myelodysplastic syndromes (MDS). The bone marrow is the body’s blood cell factory. In myelodysplastic syndromes (MDS) the bone marrow does not produce enough blood cells. This can lead to problems such as , bleeding or infections. Sometimes, MDS can develop into leukaemia. But the risk of this happening is different for each person.
Recruitment start: 1 April 2008
Recruitment end: 31 December 2027
Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.
Dr Catherine Cargo
European LeukaemiaNet MDS Work Group
Experimental Cancer Medicine Centre (ECMC)
Novartis
University Medical Center Nijmegen St Radboud
Last reviewed: 25 Nov 2025
CRUK internal database number: 4169

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.